Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
Fei Chen, Yankun Zhang, Xiaoyun Li, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

COVID-19–associated Lung Microvascular Endotheliopathy: A “From the Bench” Perspective
Jérémie Joffre, Lauren Rodriguez, Zachary A. Matthay, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 8, pp. 961-972
Open Access | Times Cited: 44
HLA alleles associated with COVID-19 susceptibility and severity in different populations: a systematic review
Meryem Fakhkhari, Hayat Caidi, Khalid Sadki
Egyptian Journal of Medical Human Genetics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 18
Potential convergence of olfactory dysfunction in Parkinson’s disease and COVID-19: The role of neuroinflammation
Hui Li, Junliang Qian, Youcui Wang, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102288-102288
Closed Access | Times Cited: 7
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 23
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Ebene R. Haycroft, Samantha K. Davis, Pradhipa Ramanathan, et al.
Medical Microbiology and Immunology (2023) Vol. 212, Iss. 4, pp. 291-305
Open Access | Times Cited: 11
Population-specific polymorphisms and SARS-CoV-2 infectivity
Nikita Jain, Shampa Chatterjee
Elsevier eBooks (2025), pp. 75-87
Closed Access
Isorhamnetin alleviates pathological damage in influenza A virus strain PR8-induced pneumonia by activating the Nrf2/HO-1 pathway and suppressing apoptosis
Yingli Xu, Shuran Li, Ronghua Zhao, et al.
Science of Traditional Chinese Medicine (2025)
Open Access
Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course
Mykhailo Buchynskyi, Iryna Kamyshna, Iryna Halabitska, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 156-156
Open Access
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines
Gelareh Abdolmaleki, Mina Taheri, Sarina Paridehpour, et al.
DARU Journal of Pharmaceutical Sciences (2022) Vol. 30, Iss. 2, pp. 379-406
Open Access | Times Cited: 18
The Impact of COVID-19 on Mortality in Italy: Retrospective Analysis of Epidemiological Trends
Alessandro Rovetta, Akshaya Srikanth Bhagavathula
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 4, pp. e36022-e36022
Open Access | Times Cited: 17
An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
Christian Devaux, Laurence Camoin‐Jau
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 17
Predictive Factors and ACE-2 Gene Polymorphisms in Susceptibility to Long COVID-19 Syndrome
David Varillas‐Delgado, Carmen Jiménez‐Antona, Angel Lizcano‐Álvarez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16717-16717
Open Access | Times Cited: 10
Association Between ACE2 and Lung Diseases
Cheng Su, Li Cai, Xinyi Hu, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 1771-1780
Open Access | Times Cited: 3
ACE2 receptor polymorphism in humans and animals increases the risk of the emergence of SARS-CoV-2 variants during repeated intra- and inter-species host-switching of the virus
Christian Devaux, Jacques Fantini
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Angiotensin-Converting Enzyme 2-Based Biosensing Modalities and Devices for Coronavirus Detection
Ijaz Gul, Shiyao Zhai, Xiaoyun Zhong, et al.
Biosensors (2022) Vol. 12, Iss. 11, pp. 984-984
Open Access | Times Cited: 11
The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study
Haixia Fu, Xuan Cai, Lijuan Cui, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1549-1559
Closed Access | Times Cited: 2
Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies
Carolina Corrêa Giron, Aatto Laaksonen, Fernando Luís Barroso da Silva
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 12, pp. 5707-5727
Open Access | Times Cited: 9
A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets
Pia V. Sodhi, Francoise Sidime, David Tarazona, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 13-13
Open Access | Times Cited: 9
Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
Md. Abdul Aziz, Mohammad Safiqul Islam
Molecular Genetics & Genomic Medicine (2022) Vol. 10, Iss. 11
Open Access | Times Cited: 8
The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations
Minela Aida Mărănducă, Calin George Vamesu, Daniela Maria Tănase, et al.
Medicina (2022) Vol. 58, Iss. 12, pp. 1717-1717
Open Access | Times Cited: 8
Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection
Abdelrahim Maen, Betül Gök Yavuz, Yehia I. Mohamed, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Immunology of SARS-CoV-2 Infection
Aida G. Gabdoulkhakova, Rimma N. Mingaleeva, Albina M. Romozanova, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 1, pp. 65-83
Closed Access | Times Cited: 1
Polymorphisms in the human angiotensin converting enzyme gene (ACE) linked to susceptibility of COVID-19 and malaria infections in the Ghanaian population
Nancy Odurowah Duah-Quashie, Philip Opoku-Agyeman, Marta Lanza, et al.
Infection Genetics and Evolution (2024) Vol. 119, pp. 105568-105568
Open Access | Times Cited: 1
Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking
Sally Badawi, Feda E. Mohamed, Nesreen R. Alkhofash, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Effect of Norelgestromin and Ethinylestradiol in Transdermal Patches on the Clinical Outcomes and Biochemical Parameters of COVID-19 Patients: A Clinical Trial Pilot Study
Alfredo Cortés-Algara, Noemí Cárdenas‐Rodríguez, Samuel Reyes-Long, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 757-757
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top